New study aims to sharpen detection of breast cancer metastases

NCT ID NCT07523516

Not yet recruiting Diagnosis Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare two types of scans—PET/CT and CT—to see which is better at finding distant spread of breast cancer. About 97 patients with advanced breast cancer will receive both scans within a few weeks. The goal is to improve early staging and guide treatment to improve survival and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: F18-FDG (a radioactive tracer used in PET/CT scans)
What this could lead to: If successful, this could show that PET/CT is more accurate than standard CT for finding cancer spread, leading to better treatment decisions and outcomes.
What could go wrong: This is a small, early-stage study (97 participants) that has not yet started recruiting. Results may not apply to all breast cancer patients, and the tracer involves radiation exposure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm Neoplasm Metastasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)

More trials for these conditions

Other studies related to the condition(s) this trial covers.